Development and evaluation of assays for the determination of total and pancreatic amylase at 37°C according to the principle recommended by the IFCC

Rauscher, 1986, Ethylidene protected substrate for the assay of human α-amylase, Fresenius Z Anal Chem, 324, 304, 10.1007/BF00487947

Haegele, 1989, Mechanism of action of human pancreatic and salivary α-amylase on 4,6-ethylidene-4-nitrophenylmaltoheptaoside substrate, Clin Chem, 35, 188, 10.1093/clinchem/35.1.188

Lorentz, 1998, Approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 9. IFCC method for α-amylase (1,4-α-D-glucan-4-glucanohydrolase, EC 3.2.1.1), Clin Chem Lab Med, 36, 185, 10.1515/CCLM.1998.034

Gerber, 1985, Specific immunoassay of α-amylase isoenzymes in human serum, Clin Chem, 31, 1331, 10.1093/clinchem/31.8.1331

Gerber, 1987, A monoclonal antibody that specifically inhibits human salivary α-amylase, Clin Chem, 33, 1158, 10.1093/clinchem/33.7.1158

Gerber, 1988, Fortschritte in der spezifischen Bestimmung der Pankreas α-amylase, Lab Med (Germany), 3, 110

Rauscher, 1985, Optimized conditions for determining activity concentration of α-amylase in serum, with 1,4-D-4-nitrophenylmaltoheptaoside as substrate, Clin Chem, 31, 14, 10.1093/clinchem/31.1.14

Lorentz, 1982, Properties of human alpha-amylases from urine, pancreas and saliva, Enzyme, 28, 233, 10.1159/000459107

Kruse-Jarres, 1989, Evaluation of a new α-amylase assay using 4,6-ethylidene-(G7)-1,4-nitrophenyl-(G1)-,D-maltoheptaoside as substrate, J Clin Chem Clin Biochem, 27, 103

Junge, 1989, Evaluation of a new assay for pancreatic amylase, Clin Biochem, 22, 109, 10.1016/S0009-9120(89)80007-4

Tietz, 1988, A multicenter evaluation of a specific pancreatic isoamylase assay using a double monoclonal antibody technique, Clin Chem, 34, 2096, 10.1093/clinchem/34.10.2096

Haegele, 1983, Mechanism of action of human pancreatic and salivary α-amylase on α−4-nitrophenyl maltoheptaoside substrate, Clin Chem, 28, 2201, 10.1093/clinchem/28.11.2201

Bablok, 1993, Biometrical methods—between-day imprecision, 205

Glick, 1986, Graphical comparisons of interferences in clinical chemistry instrumentation, Clin Chem, 32, 470, 10.1093/clinchem/32.3.470

Young, 1990

Passing, 1983, A new biometrical procedure for testing the equality of measurements from two different analytical methods, J Clin Chem Clin Biochem, 21, 709

Stamm, 1995, “Normalwerte” und Referenzwerte, 71

Farrar, 1978, Sensitivity of the amylase-creatinine clearance ratio in acute pancreatitis, Arch Intern Med, 138, 958, 10.1001/archinte.138.6.958

Warshaw, 1976, The mechanism of increased renal clearance of amylase in acute pancreatitis, Gastroenterology, 71, 388, 10.1016/S0016-5085(76)80441-6

Junge, 1985, The role of the kidney in the elimination of pancreatic lipase and amylase from blood, J Clin Chem Clin Biochem, 23, 387

Lorentz, 2000, Routine α-amylase assay using protected 4-nitrophenyl-1,4-.D-maltoheptaoside, and a novel α-glucosidase, Clin Chem, 46, 644, 10.1093/clinchem/46.5.644

Bergmeyer, 1983, Establishing optimum measurement conditions, 114

Berk, 1980, Hyperamylasemia, Adv Intern Med, 26, 235

Salt, 1976, Amylase—its clinical significance, Medicine, 55, 269, 10.1097/00005792-197607000-00001

Kameya, 1986, Hyperamylasemia in patients at an intensive care unit, J Clin Gastroenterol, 8, 438, 10.1097/00004836-198608000-00011

Mifflin, 1989, Interaction of immobilized anti-salivary amylase antibody with human macroamylases, Clin Chem, 35, 1651, 10.1093/clinchem/35.8.1651

Hohenwallner, 1989, Reference ranges for alpha-amylase in serum and urine with 4,6-ethylidene-(G7)-1–4-nitrophenyl-(G1)-alpha-D-maltoheptaoside as substrate, J Clin Chem Clin Biochem, 27, 97